Skip to main content
Log in

Basic requirements for the toxicity testing of antimicrobial agents

  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The regulations in different countries on the toxicological testing of antimicrobial agents are similar and harmonized on an international basis. Existing requirements cover both the standard investigations performed with any other new class of therapeutic drug and investigations necessary due to the specific features of anti-infective agents. Such features are the therapeutic target (the microorganisms), the need to provide adequate treatment of patients even during clinical trials, and the potential of the drug to induce certain adverse reactions. The combination of toxicity tests used will be determined by the drug, its class and current knowledge.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Commission of the European Communities: Notice to applicants. In: The rules governing medicinal products in the European Community. Volume 2. Brussels, 1989, p. 1–175.

    Google Scholar 

  2. Japanese Ministry of Health and Welfare: Notification No. 1–24 of the Pharmaceuticals Affairs Bureau (September 11, 1989). Tokyo, 1989.

  3. Nordic Council on Medicine: Clinical trials of drugs. Nordic Guidelines. NLN Publication No. 11. Nordiska Läkemedelsnämnden, Uppsala, 1983.

    Google Scholar 

  4. US Food and Drug Administration: New drug, antibiotic and biologic drug product regulations. Final rule. 21 CFR Parts 312, 314, 511, and 514. Federal Register March 19, 1987, Vol. 52, No. 53.

  5. US Food and Drug Administration and the Infectious Disease Society of America: General guidelines for the clinical evaluation of antiinfective drugs. Washington, DC, 1990.

  6. Commission of the European Communities: Single dose toxicity. Note for guidance (March 16, 1987). Official Journal of the European Communities 1987, 30: 2–3.

    Google Scholar 

  7. Commission of the European Communities: Repeated dose toxicity. Note for guidance (November 28, 1983). Official Journal of the European Communities 1983, 26: 12–17.

    Google Scholar 

  8. Commission of the European Communities: Local tolerance testing of medicinial products. Note for guidance (Draft of February 1990). CEC III/3979/88-En. Brussels, 1990.

  9. Zbinden G, Gross F (ed): Pharmacological methods in toxicology. Pergamon Press, Oxford, 1979.

    Google Scholar 

  10. Commission of the European Communities: Reproduction studies. Note for guidance (November 28, 1983). Official Journal of the European Communities 1983, 26: 20–22.

    Google Scholar 

  11. Commission of the European Communities: Testing of medicinal products for their mutagenic potential. Note for guidance (March 16, 1987). Official Journal of the European Comunities, 1987, 30: 4–6.

    Google Scholar 

  12. Commission of the European Communities: Carcinogenic potential. Note for guidance (November 28, 1983). Official Journal of the European Communities, 1983, 26: 23–28.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bass, R., Lehnert, T. Basic requirements for the toxicity testing of antimicrobial agents. Eur. J. Clin. Microbiol. Infect. Dis. 9, 488–491 (1990). https://doi.org/10.1007/BF01964288

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01964288

Keywords

Navigation